Durham, NC, United States of America

Neil Lee Spector

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 105(Granted Patents)


Location History:

  • Chapel Hill, NC (US) (2001 - 2013)
  • Durham, NC (US) (2010 - 2024)

Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Neil Lee Spector: Innovator in Cancer Therapy

Introduction

Neil Lee Spector is a prominent inventor based in Durham, NC (US), known for his significant contributions to cancer treatment technologies. With a total of 11 patents to his name, Spector has made remarkable strides in the field of medical innovation.

Latest Patents

Among his latest patents is the X-ray psoralen activated cancer therapy (X-PACT), which presents a method for treating diseased sites in human or animal bodies. This method involves injecting phosphors capable of emitting ultraviolet or visible light into the affected area. Additionally, he has developed a system for the same therapy, which includes a pharmaceutical carrier with phosphors, a photoactivatable drug for DNA intercalation, devices for drug infusion, and a processor to control the dose of x-rays or electrons. This innovative approach aims to activate the photoactivatable drug within tumors, enhancing treatment efficacy.

Career Highlights

Spector has worked with notable institutions such as Duke University and Immunolight, LLC. His work has focused on advancing cancer therapies through innovative technologies and methodologies.

Collaborations

Some of his notable coworkers include Harold Walder and Wenle Xia, who have contributed to his research and development efforts.

Conclusion

Neil Lee Spector's work in cancer therapy exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…